{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:22:36Z","timestamp":1778937756310,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41417-021-00406-5","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T08:02:59Z","timestamp":1637308979000},"page":"1012-1020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression"],"prefix":"10.1038","volume":"29","author":[{"given":"Hua-Dong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hai","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8575-0078","authenticated-orcid":false,"given":"Wen-Zong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"406_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","volume":"4","author":"S Misra","year":"2003","unstructured":"Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167\u201376.","journal-title":"Lancet Oncol"},{"key":"406_CR2","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jama.2018.11815","volume":"320","author":"I Baiu","year":"2018","unstructured":"Baiu I, Visser B. Gallbladder cancer. JAMA 2018;320:1294.","journal-title":"JAMA"},{"key":"406_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","volume":"51","author":"EC Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce EC, Miquel JF, Mu\u00f1oz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349\u201364.","journal-title":"CA Cancer J Clin"},{"key":"406_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u20135.","journal-title":"Nat Chem Biol"},{"key":"406_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18\u201329.","journal-title":"Mol Cell"},{"key":"406_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nchembio.687","volume":"7","author":"G Jia","year":"2011","unstructured":"Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7:885\u20137.","journal-title":"Nat Chem Biol"},{"key":"406_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","volume":"28","author":"DP Patil","year":"2018","unstructured":"Patil DP, Pickering BF, Jaffrey SR. Reading m(6)A in the Transcriptome: m(6)A-Binding Proteins. Trends Cell Biol. 2018;28:113\u201327.","journal-title":"Trends Cell Biol"},{"key":"406_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 2014;505:117\u201320.","journal-title":"Nature"},{"key":"406_CR9","doi-asserted-by":"publisher","first-page":"11356","DOI":"10.1093\/nar\/gkx778","volume":"45","author":"M Bartosovic","year":"2017","unstructured":"Bartosovic M, Molares HC, Gregorova P, Hrossova D, Kudla G, Vanacova S. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3\u2019-end processing. Nucleic Acids Res. 2017;45:11356\u201370.","journal-title":"Nucleic Acids Res"},{"key":"406_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ncb2902","volume":"16","author":"Y Wang","year":"2014","unstructured":"Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol. 2014;16:191\u20138.","journal-title":"Nat Cell Biol"},{"key":"406_CR11","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, et al. 5\u2019 UTR m(6)A promotes cap-independent translation. Cell 2015;163:999\u20131010.","journal-title":"Cell"},{"key":"406_CR12","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, et al. N(6)-methyladenosine modulates messenger rna translation Efficiency. Cell 2015;161:1388\u201399.","journal-title":"Cell"},{"key":"406_CR13","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u201370.","journal-title":"Hepatology"},{"key":"406_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1146-4","volume":"19","author":"X Yang","year":"2020","unstructured":"Yang X, Zhang S, He C, Xue P, Zhang L, He Z, et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer. 2020;19:46.","journal-title":"Mol Cancer"},{"key":"406_CR15","doi-asserted-by":"publisher","first-page":"102821","DOI":"10.1016\/j.ebiom.2020.102821","volume":"56","author":"A Xie","year":"2020","unstructured":"Xie A, Hanif S, Ouyang J, Tang Z, Kong N, Kim NY, et al. Stimuli-responsive prodrug-based cancer nanomedicine. EBioMedicine 2020;56:102821.","journal-title":"EBioMedicine"},{"key":"406_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.7150\/ijbs.39779","volume":"16","author":"HD Chen","year":"2020","unstructured":"Chen HD, Huang CS, Xu QC, Li F, Huang XT, Wang JQ, et al. Therapeutic targeting of CDK7 suppresses tumor progression in intrahepatic Cholangiocarcinoma. Int J Biol Sci. 2020;16:1207\u201317.","journal-title":"Int J Biol Sci"},{"key":"406_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1109-9","volume":"18","author":"L He","year":"2019","unstructured":"He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.","journal-title":"Mol Cancer"},{"key":"406_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, et al. METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut 2020;69:1193\u2013205.","journal-title":"Gut"},{"key":"406_CR19","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1111\/jcmm.15063","volume":"24","author":"H Xie","year":"2020","unstructured":"Xie H, Li J, Ying Y, Yan H, Jin K, Ma X, et al. METTL3\/YTHDF2 m(6) a axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer. J Cell Mol Med. 2020;24:4092\u2013104.","journal-title":"J Cell Mol Med"},{"key":"406_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62:335\u201345.","journal-title":"Mol Cell"},{"key":"406_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2017.11.018","volume":"415","author":"X Cai","year":"2018","unstructured":"Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang Z, et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. Cancer Lett. 2018;415:11\u20139.","journal-title":"Cancer Lett"},{"key":"406_CR22","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-18-2868","volume":"79","author":"F Li","year":"2019","unstructured":"Li F, Yi Y, Miao Y, Long W, Long T, Chen S, et al. N(6)-Methyladenosine modulates nonsense-mediated mRNA decay in human glioblastoma. Cancer Res. 2019;79:5785\u201398.","journal-title":"Cancer Res"},{"key":"406_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376.","journal-title":"Nat Med"},{"key":"406_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"406_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"406_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.328","volume":"8","author":"J Ding","year":"2017","unstructured":"Ding J, Li J, Wang H, Tian Y, Xie M, He X, et al. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5\/CDKN1A expression. Cell Death Dis. 2017;8:e2997.","journal-title":"Cell Death Dis"},{"key":"406_CR27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/15384047.2020.1806641","volume":"21","author":"H Min","year":"2020","unstructured":"Min H, He W. Long non-coding RNA ARAP1-AS1 promotes the proliferation and migration in cervical cancer through epigenetic regulation of DUSP5. Cancer Biol Ther. 2020;21:907\u201314.","journal-title":"Cancer Biol Ther"},{"key":"406_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/jcp.29010","volume":"235","author":"M Du","year":"2020","unstructured":"Du M, Zhuang Y, Tan P, Yu Z, Zhang X, Wang A. microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5. J Cell Physiol. 2020;235:944\u201356.","journal-title":"J Cell Physiol"},{"key":"406_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/cas.13858","volume":"110","author":"R Wang","year":"2019","unstructured":"Wang R, Bao HB, Du WZ, Chen XF, Liu HL, Han DY, et al. P68 RNA helicase promotes invasion of glioma cells through negatively regulating DUSP5. Cancer Sci. 2019;110:107\u201317.","journal-title":"Cancer Sci"},{"key":"406_CR30","first-page":"844","volume":"11","author":"L Wang","year":"2019","unstructured":"Wang L, Hu J, Qiu D, Gao H, Zhao W, Huang Y, et al. Dual-specificity phosphatase 5 suppresses ovarian cancer progression by inhibiting IL-33 signaling. Am J Transl Res. 2019;11:844\u201354.","journal-title":"Am J Transl Res"},{"key":"406_CR31","doi-asserted-by":"publisher","first-page":"738","DOI":"10.7150\/ijms.24981","volume":"15","author":"T Liu","year":"2018","unstructured":"Liu T, Sun H, Liu S, Yang Z, Li L, Yao N, et al. The suppression of DUSP5 expression correlates with paclitaxel resistance and poor prognosis in basal-like breast cancer. Int J Med Sci. 2018;15:738\u201347.","journal-title":"Int J Med Sci"},{"key":"406_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/1759-7714.13270","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Xing Y, Jiang S, Xu C, Zhou X, Zhang R, et al. Integrated analysis identifies DUSP5 as a novel prognostic indicator for thyroid follicular carcinoma. Thorac Cancer. 2020;11:336\u201345.","journal-title":"Thorac Cancer"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00406-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T23:03:50Z","timestamp":1658185430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-021-00406-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1038\/s41417-021-00406-5","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,19]]},"assertion":[{"value":"20 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}